Literature DB >> 28512230

Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.

Zhuona Rong1, Tingting Fan1, Huiling Li1, Juan Li1, Kangwei Wang1, Xinxin Wang1, Jianyi Dong1, Jun Chen1, Fujin Wang1, Jingyu Wang2, Aiguo Wang2.   

Abstract

Male prevalence is an outstanding characteristic of hepatocellular carcinoma (HCC), and the underlying mechanisms for this have remained largely unknown. In the present study, Hras12V transgenic mice, in which hepatocyte-specific expression of the ras oncogene induces male-biased hepatic tumorigenesis, were studied, and altered proteins were detected by two-dimensional fluorescence difference gel electrophoresis (2D-DIGE). Protein samples from hepatic tumor tissues (T) and peritumor tissues (P) of transgenic males and females and the corresponding normal liver tissues (Wt) of nontransgenic males and females were subjected to pairwise comparisons based on proteomic analysis. Among 2381 autodetected protein spots, more than 1600 were differentially expressed based on a pairwise comparison (|ratio| > = 1.5, p < = 0.05). Of these, 180 spots were randomly selected for matrix-assisted laser desorption ionization tandem time-of-flight mass spectrometry (MALDI-TOF/TOF MS) identification; finally, 89 distinct proteins were obtained. Among these 89 proteins, 7 and 50 proteins were further validated by Western blotting and literature investigation, respectively. Intriguingly, compared with Wt, the altered proteins were relatively concentrated in T in transgenic females but in P in transgenic males. Consistently, the levels of p-ERK and p-mTOR were significantly higher in the T of females compared with that of males. The pathway enrichment assay showed that 5 pathways in males but only 1 in females were significantly altered in terms of the upregulated proteins in T compared with Wt. These data indicate that female hepatocytes are disturbed by oncogenes with great difficulty, whereas male hepatocytes readily do so. In addition, 33 proteins were gender-dependently altered in hepatic tumorigenesis. Moreover, 4% DNA packaging and 4% homeostasis-related functional proteins were found in females but not in males, and more nucleus proteins were found in females (8%) than in males (3%). In conclusion, the proteomic data and comparative analysis presented here offer crucial clues for elucidating the mechanisms that underlie the male prevalence in HCC.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28512230      PMCID: PMC5546199          DOI: 10.1074/mcp.M116.065474

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  71 in total

1.  Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis.

Authors:  Elizabeth Brandon-Warner; Tracy L Walling; Laura W Schrum; Iain H McKillop
Journal:  Alcohol Clin Exp Res       Date:  2011-10-21       Impact factor: 3.455

2.  Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression.

Authors:  Khairy M A Zoheir; Ahmed A Abd-Rabou; Gamaleldin I Harisa; Abdelkader E Ashour; Sheikh Fayaz Ahmad; Sabry M Attia; Saleh A Bakheet; Hala E Abdel-Hamied; Adel R Abd-Allah; Ashok Kumar
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  Hepatocellular carcinoma in Chinese males and females. Possible causes for the male predominance.

Authors:  C L Lai; P B Gregory; P C Wu; A S Lok; K P Wong; M M Ng
Journal:  Cancer       Date:  1987-09-01       Impact factor: 6.860

4.  Gender disparity of hepatocellular carcinoma: the roles of sex hormones.

Authors:  Shiou-Hwei Yeh; Pei-Jer Chen
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

5.  Gender-based outcomes differences in unresectable hepatocellular carcinoma.

Authors:  Shama C Buch; Venkateswarlu Kondragunta; Robert A Branch; Brian I Carr
Journal:  Hepatol Int       Date:  2007-12-15       Impact factor: 6.047

6.  Orchiectomy reduces hepatotumorigenesis of H-ras12V transgenic mice via the MAPK pathway.

Authors:  Ai-Guo Wang; Hyung-Bae Moon; Sang-Young Chun; Tae-Hoon Lee; Dae-Yeul Yu; Dong-Seok Lee
Journal:  Life Sci       Date:  2006-06-27       Impact factor: 5.037

7.  Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: potential prognostic marker and target for tumourigenicity-suppression.

Authors:  Elwin A Morgan; Shiva S Forootan; Janet Adamson; Christopher S Foster; Hiroshi Fujii; Michihiro Igarashi; Carol Beesley; Paul H Smith; Youqiang Ke
Journal:  Int J Oncol       Date:  2008-04       Impact factor: 5.650

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

Review 9.  Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors.

Authors:  R R Maronpot; T Fox; D E Malarkey; T L Goldsworthy
Journal:  Toxicology       Date:  1995-08-25       Impact factor: 4.221

10.  Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Authors:  Xin-Zhong Chang; Da-Qiang Li; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Gen-Hong Di; Wei Jin; Zhou-Luo Ou; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  5 in total

1.  Differential Proteomic Analysis of Hepatocellular Carcinomas from Ppp2r5d Knockout Mice and Normal (Knockout) Livers.

Authors:  Caroline Lambrecht; Gabriela Bomfim Ferreira; Judit DomÈnech Omella; Louis Libbrecht; Rita DE Vos; Rita Derua; Chantal Mathieu; Lut Overbergh; Etienne Waelkens; Veerle Janssens
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

2.  Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.

Authors:  Tingting Fan; Zhuona Rong; Jianyi Dong; Juan Li; Kangwei Wang; Xinxin Wang; Huiling Li; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Cancer Med       Date:  2017-09-21       Impact factor: 4.452

Review 3.  Molecular Markers in Sex Differences in Cancer.

Authors:  Ji Yoon Shin; Hee Jin Jung; Aree Moon
Journal:  Toxicol Res       Date:  2019-10-15

4.  Role of the Mitochondrial Citrate-malate Shuttle in Hras12V-Induced Hepatocarcinogenesis: A Metabolomics-Based Analysis.

Authors:  Chuanyi Lei; Jun Chen; Huiling Li; Tingting Fan; Xu Zheng; Hong Wang; Nan Zhang; Yang Liu; Xiaoqin Luo; Jingyu Wang; Aiguo Wang
Journal:  Metabolites       Date:  2020-05-13

5.  Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis.

Authors:  Huiling Li; Zhuona Rong; Hong Wang; Nan Zhang; Chunwen Pu; Yi Zhao; Xu Zheng; Chuanyi Lei; Yang Liu; Xiaoqin Luo; Jun Chen; Fujin Wang; Aiguo Wang; Jingyu Wang
Journal:  Biol Sex Differ       Date:  2020-08-13       Impact factor: 5.027

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.